Selected
Type of publications
Topics
Available to download in languages
Regions
Diseases
4115 results found
2023 ∙ Amisha, F. Saluja, P. Malik, P. Van Rhee, F.
Acquired hemophilia A (AHA) due to anti-SARS-CoV-2 vaccination: A systematic review
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Nabizadeh, F. Noori, M. Rahmani, S. Hosseini, H.
Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: A systematic review
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Pichichero, Michael Malley, Richard Kaur, Ravinder Zagursky, Robert Anderson, Porter
Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Liatsou, E. Ntanasis-Stathopoulos, I. Lykos, S. Ntanasis-Stathopoulos, A. Gavriatopoulou, M. Psaltopoulou, T. Sergentanis, T. N. Terpos, E.
Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Putri, E. A. C. Munir, M. Setiawan, H. K. Herawati, L. Sari, G. M. Wungu, C. D. K. Susilo, H. Sutanto, H.
Adverse cardiac events following mRNA COVID-19 vaccination: A systematic review and meta-analysis
  • Vaccine/vaccination
  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Yasmin, F. Najeeb, H. Naeem, U. Moeed, A. Atif, A. R. Asghar, M. S. Nimri, N. Saleem, M. Bandyopadhyay, D. Krittanawong, C. Fadelallah Eljack, M. M. Tahir, M. J. Waqar, F.
Adverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Zhang, H. Q. Cao, B. Z. Cao, Q. T. Hun, M. Cao, L. Zhao, M. Y.
An analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Bachour, Y.
An update and overview of the literature on late inflammatory reactions (LIRs) in soft tissue fillers after SARS-CoV-2 infection and vaccination
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Dimitroglou, Margarita Sokou, Rozeta Iacovidou, Nicoletta Pouliakis, Abraham Kafalidis, Georgios Boutsikou, Theodora Iliodromiti, Zoi
Anti-SARS-CoV-2 Immunoglobulins in Human Milk after Coronavirus Disease or Vaccination-Time Frame and Duration of Detection in Human Milk and Factors That Affect Their Titers: A Systematic Review
  • Vaccine/vaccination
  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Roslan, M. Nisfu, F. R. M. Arzmi, M. H. Wahab, R. A. Zainuddin, N.
Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 Messenger Ribonucleic Acid Vaccines in Infected Individuals: A Systematic Review
  • Vaccine/vaccination
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Rating:
Critically low